[go: up one dir, main page]

NO984198D0 - Fremgangsmåte for behandling av aggresjon - Google Patents

Fremgangsmåte for behandling av aggresjon

Info

Publication number
NO984198D0
NO984198D0 NO984198A NO984198A NO984198D0 NO 984198 D0 NO984198 D0 NO 984198D0 NO 984198 A NO984198 A NO 984198A NO 984198 A NO984198 A NO 984198A NO 984198 D0 NO984198 D0 NO 984198D0
Authority
NO
Norway
Prior art keywords
aggression
treating
treating aggression
olanzapine
administering
Prior art date
Application number
NO984198A
Other languages
English (en)
Other versions
NO984198L (no
NO323579B1 (no
Inventor
Jr Charles M Beasley
Pierre V Tran
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984198D0 publication Critical patent/NO984198D0/no
Publication of NO984198L publication Critical patent/NO984198L/no
Publication of NO323579B1 publication Critical patent/NO323579B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Pyrane Compounds (AREA)
NO19984198A 1996-03-11 1998-09-11 Anvendelse av olanzapin for fremstilling av et legemiddel for behandling av ekstrem aggresjon NO323579B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1312796P 1996-03-11 1996-03-11
PCT/US1996/019573 WO1997033584A1 (en) 1996-03-11 1996-12-04 Method for treating excessive aggression

Publications (3)

Publication Number Publication Date
NO984198D0 true NO984198D0 (no) 1998-09-11
NO984198L NO984198L (no) 1998-11-02
NO323579B1 NO323579B1 (no) 2007-06-11

Family

ID=21758447

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984198A NO323579B1 (no) 1996-03-11 1998-09-11 Anvendelse av olanzapin for fremstilling av et legemiddel for behandling av ekstrem aggresjon

Country Status (22)

Country Link
EP (1) EP0900085B1 (no)
JP (1) JP2000506858A (no)
KR (1) KR19990087716A (no)
CN (1) CN1124847C (no)
AT (1) ATE306269T1 (no)
AU (1) AU719517B2 (no)
BR (1) BR9612549A (no)
CA (1) CA2248753C (no)
CZ (1) CZ296579B6 (no)
DE (1) DE69635282T2 (no)
DK (1) DK0900085T3 (no)
EA (1) EA000741B1 (no)
ES (1) ES2249789T3 (no)
HU (1) HUP9903685A3 (no)
IL (1) IL126157A (no)
NO (1) NO323579B1 (no)
NZ (1) NZ325035A (no)
PL (1) PL186975B1 (no)
RO (1) RO117347B1 (no)
TR (1) TR199801799T2 (no)
UA (1) UA57727C2 (no)
WO (1) WO1997033584A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000030648A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
CA2351718A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
AU757870B2 (en) * 1998-11-23 2003-03-06 Sepracor, Inc. Pharmaceutical compositions containing olanzapine-N-oxide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595535A (en) * 1983-06-06 1986-06-17 Ciba-Geigy Corporation Diazacycloalkyl-1,2,4-triazolo[2,3-c][1,3]benzodiazepines useful as neuroleptic and/or antihistaminic agents
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
JPH11506096A (ja) * 1995-05-30 1999-06-02 イーライ・リリー・アンド・カンパニー 認識機能不全を処置する方法

Also Published As

Publication number Publication date
PL328949A1 (en) 1999-03-01
NZ325035A (en) 2001-06-29
NO984198L (no) 1998-11-02
CZ296579B6 (cs) 2006-04-12
CN1213969A (zh) 1999-04-14
EP0900085B1 (en) 2005-10-12
HUP9903685A3 (en) 2001-12-28
BR9612549A (pt) 1999-07-20
TR199801799T2 (xx) 1999-01-18
RO117347B1 (ro) 2002-02-28
UA57727C2 (uk) 2003-07-15
HUP9903685A2 (hu) 2000-03-28
CA2248753A1 (en) 1997-09-18
IL126157A0 (en) 1999-05-09
NO323579B1 (no) 2007-06-11
CA2248753C (en) 2008-11-18
EA199800822A1 (ru) 1999-02-25
WO1997033584A1 (en) 1997-09-18
JP2000506858A (ja) 2000-06-06
ATE306269T1 (de) 2005-10-15
AU719517B2 (en) 2000-05-11
EP0900085A1 (en) 1999-03-10
ES2249789T3 (es) 2006-04-01
CN1124847C (zh) 2003-10-22
DE69635282T2 (de) 2006-04-20
DE69635282D1 (de) 2006-02-23
EA000741B1 (ru) 2000-02-28
EP0900085A4 (en) 2000-12-13
DK0900085T3 (da) 2006-01-30
AU1284697A (en) 1997-10-01
PL186975B1 (pl) 2004-04-30
IL126157A (en) 2002-09-12
CZ290598A3 (cs) 1999-09-15
KR19990087716A (ko) 1999-12-27

Similar Documents

Publication Publication Date Title
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DK0811110T3 (da) Oliekildebehandling
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
EA199800866A1 (ru) Способ снятия боли
NO965497L (no) Fremgangsmåte for kontrollert fiksering av avleiringsinhibitor i en underjordisk formasjon
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO984198D0 (no) Fremgangsmåte for behandling av aggresjon
NO982562D0 (no) Sammensetning for behandling av smerte
DE69412178D1 (de) Apparat zur Behandlung von Lagen
NO984197D0 (no) Fremgangsmåte for behandling av autisme
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO990949D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av AIDS
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
EA199800818A1 (ru) Способ лечения бессонницы
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
UA43389C2 (uk) Спосіб зниження рівнів кальцію у сироватці
BA95039A (bs) Set za prevenciju i terapiju bolne menstruacije
SE9504669D0 (sv) Positionerbar behandlingskateter
UA25399A (uk) Спосіб лікуваhhя хворих гломерулоhефритом
YU40198A (sh) Postupak za tretiranje zavisnosti od supstance
EE9500065A (et) Meetod ravimuda ettevalmistamiseks
FI103753B1 (fi) Menetelmä väkirehun käsittelemiseksi